Actinium Pharmaceuticals, Inc. (ATNM)
1 Item 5.02 filing since 2026-10-15 · roles: CFO. NYSE. Pharmaceutical Preparations. State: NY.
| Score | Filed | Event | Role | Person | Seat | Summary |
|---|---|---|---|---|---|---|
| 70 | 2026-10-15 | Appointment | CFO | subscribers | — | Actinium Pharmaceuticals, Inc. (ATNM): CFO Matt David appointed |
Executive changes at other companies: all filings · CEO · CFO · How Item 5.02 works